Correlation Between Capital One and CRISPR Therapeutics
Can any of the company-specific risk be diversified away by investing in both Capital One and CRISPR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Capital One and CRISPR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Capital One Financial and CRISPR Therapeutics AG, you can compare the effects of market volatilities on Capital One and CRISPR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Capital One with a short position of CRISPR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Capital One and CRISPR Therapeutics.
Diversification Opportunities for Capital One and CRISPR Therapeutics
-0.36 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Capital and CRISPR is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Capital One Financial and CRISPR Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CRISPR Therapeutics and Capital One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Capital One Financial are associated (or correlated) with CRISPR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CRISPR Therapeutics has no effect on the direction of Capital One i.e., Capital One and CRISPR Therapeutics go up and down completely randomly.
Pair Corralation between Capital One and CRISPR Therapeutics
Assuming the 90 days trading horizon Capital One Financial is expected to generate 0.33 times more return on investment than CRISPR Therapeutics. However, Capital One Financial is 2.99 times less risky than CRISPR Therapeutics. It trades about 0.1 of its potential returns per unit of risk. CRISPR Therapeutics AG is currently generating about -0.01 per unit of risk. If you would invest 53,796 in Capital One Financial on November 18, 2024 and sell it today you would earn a total of 4,504 from holding Capital One Financial or generate 8.37% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Capital One Financial vs. CRISPR Therapeutics AG
Performance |
Timeline |
Capital One Financial |
CRISPR Therapeutics |
Capital One and CRISPR Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Capital One and CRISPR Therapeutics
The main advantage of trading using opposite Capital One and CRISPR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Capital One position performs unexpectedly, CRISPR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CRISPR Therapeutics will offset losses from the drop in CRISPR Therapeutics' long position.Capital One vs. Chunghwa Telecom Co, | ||
Capital One vs. METISA Metalrgica Timboense | ||
Capital One vs. Liberty Broadband | ||
Capital One vs. Ryanair Holdings plc |
CRISPR Therapeutics vs. Nordon Indstrias Metalrgicas | ||
CRISPR Therapeutics vs. Multilaser Industrial SA | ||
CRISPR Therapeutics vs. MAHLE Metal Leve | ||
CRISPR Therapeutics vs. The Home Depot |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |